Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Cohen

Showing results (241-250 of 250) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 250 results.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2018
Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG MiceJoEllyn M McMillan, Denise A Cobb, Zhiyi Lin, et al.
Regulatory Toxicology and Pharmacology : RTP|September 13, 2016
Whither the impending european regulation of presumed endocrine disruptors?Herman N Autrup, Sir Colin L Berry, Samuel M Cohen, et al.
Archives of Toxicology|April 8, 2023
US regulations to curb alleged cancer causes are ineffectual and compromised by scientific, constitutional and ethical violationsGio B Gori, Michael Aschner, Christopher J Borgert, et al.
Regulatory Toxicology and Pharmacology : RTP|October 11, 2020
A critical review of the acetaminophen preclinical carcinogenicity and tumor promotion data and their implications for its carcinogenic hazard potentialF Jay Murray, Andrew D Monnot, David Jacobson-Kram, et al.
Regulatory Toxicology and Pharmacology : RTP|July 19, 2018
Obfuscating transparency?Michael Aschner, Herman Autrup, Colin L Berry, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
Bladder cancer. Clinical practice guidelines in oncologyJames E Montie, Robert R Bahnson, Samuel M Cohen, et al.
Human & Experimental Toxicology|January 30, 2025
Conflicts of interest in the International Agency for Research on Cancer process of identifying carcinogenic hazards to humansSusan A Elmore, Colin Berry, Brad Bolon, et al.
Molecular Biology of the Cell|October 3, 2019
Mitochondrial lipid droplet formation as a detoxification mechanism to sequester and degrade excessive urothelial membranesYi Liao, Daniel K L Tham, Feng-Xia Liang, et al.
Nature Communications|June 10, 2022
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulationSuyash Deodhar, Brady Sillman, Aditya N Bade, et al.
Toxicology|September 19, 2016
Upholding science in health, safety and environmental risk assessments and regulationsMichael Aschner, Herman N Autrup, Sir Colin L Berry, et al.
Pageof 25

Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2018
Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG MiceJoEllyn M McMillan, Denise A Cobb, Zhiyi Lin, et al.
Regulatory Toxicology and Pharmacology : RTP|September 13, 2016
Whither the impending european regulation of presumed endocrine disruptors?Herman N Autrup, Sir Colin L Berry, Samuel M Cohen, et al.
Archives of Toxicology|April 8, 2023
US regulations to curb alleged cancer causes are ineffectual and compromised by scientific, constitutional and ethical violationsGio B Gori, Michael Aschner, Christopher J Borgert, et al.
Regulatory Toxicology and Pharmacology : RTP|October 11, 2020
A critical review of the acetaminophen preclinical carcinogenicity and tumor promotion data and their implications for its carcinogenic hazard potentialF Jay Murray, Andrew D Monnot, David Jacobson-Kram, et al.
Regulatory Toxicology and Pharmacology : RTP|July 19, 2018
Obfuscating transparency?Michael Aschner, Herman Autrup, Colin L Berry, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
Bladder cancer. Clinical practice guidelines in oncologyJames E Montie, Robert R Bahnson, Samuel M Cohen, et al.
Human & Experimental Toxicology|January 30, 2025
Conflicts of interest in the International Agency for Research on Cancer process of identifying carcinogenic hazards to humansSusan A Elmore, Colin Berry, Brad Bolon, et al.
Molecular Biology of the Cell|October 3, 2019
Mitochondrial lipid droplet formation as a detoxification mechanism to sequester and degrade excessive urothelial membranesYi Liao, Daniel K L Tham, Feng-Xia Liang, et al.
Nature Communications|June 10, 2022
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulationSuyash Deodhar, Brady Sillman, Aditya N Bade, et al.
Toxicology|September 19, 2016
Upholding science in health, safety and environmental risk assessments and regulationsMichael Aschner, Herman N Autrup, Sir Colin L Berry, et al.
Pageof 25